Delivery Order SPE2DB22D9316-SPE2DB25FYP25
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). The contract, awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation applied. This award falls under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $36,440.37 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 5 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this contract at its Park Ridge facility with an ultimate completion date of July 9, 2025. This delivery order was awarded without a set-aside designation on July 8, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $24,293.60 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 5 mg tablets (60-unit quantity) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was issued without a set-aside designation and is being performed at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, serves as the prime...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $86,098.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 17, 2025. The delivery order is for Jakafi 15 mg tablets (60-count units) under a firm fixed-price contract type with an ultimate completion date of September 18, 2025. This award carries no set-aside designation and represents a direct delivery order issued against DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,089.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units). The contract, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 31, 2025, by the Defense Logistics Agency for the supply of Jakafi 10 mg tablets (60-count unit). This firm fixed-price delivery order, valued at $24,231.30, represents a single shipment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program. The contract includes no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This $12,115.65 firm fixed-price delivery order was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, and is not designated as a set-aside contract. The delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a direct pharmaceutical supply transaction under DMS's existing Indefinite Delivery Contract with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units) under firm fixed-price terms. The contract, valued at $12,146.79 with an ultimate completion date of September 22, 2025, was awarded on September 19, 2025, with no set-aside designation applied. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a direct pharmaceutical supply transaction under DLA's established procurement framework. The contract carries no...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB25FYP25Delivery Order
The Defense Logistics Agency (DLA) awarded a $24,231.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). The award, issued on June 2, 2025, with an ultimate completion date of June 3, 2025, carries no set-aside designation. DMS Pharmaceutical Group will perform this delivery order from its Park Ridge, Illinois location, supplying the medication to support federal healthcare requirements. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499,999,999 single-award contract valid through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, and biologics, to support medical supply needs across Department of Defense healthcare facilities worldwide. Jakafi (ruxolitinib), a prescription medication used in treating certain blood disorders and skin conditions, represents one of the specialized pharmaceutical products available through this framework agreement, demonstrating DMS Pharmaceutical Group's role as a critical supplier in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.2k | 6/2/25 |